Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Atai stock gains as Oppenheimer maintains rating after Lilly deal Hisse Senetleri 0 1
A Lilly to acquire AtaiBeckley for $2.8 billion upfront Hisse Senetleri 0 2
A Eli Lilly in talks to buy psychedelic drugmaker AtaiBeckley - Bloomberg Hisse Senetleri 0 2
A RBC Capital reiterates Eli Lilly stock rating on growth outlook Hisse Senetleri 0 8
A Eli Lilly shares phase 3 data on triple agonist weight loss drug retatrutide Hisse Senetleri 0 20
A Leerink reiterates Eli Lilly stock rating on gene therapy progress Hisse Senetleri 0 15
A Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Hisse Senetleri 0 23
A Lilly’s Jaypirca shows improved survival in CLL trial Hisse Senetleri 0 40

Benzer konular

Üst